Ocular Therapeutix (OCUL) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to 0.09.

  • Ocular Therapeutix's Asset Utilization Ratio fell 3657.36% to 0.09 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.09, marking a year-over-year decrease of 3657.36%. This contributed to the annual value of 0.08 for FY2025, which is 5427.83% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Asset Utilization Ratio of 0.09 as of Q4 2025, which was down 3657.36% from 0.13 recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Asset Utilization Ratio ranged from a high of 0.43 in Q2 2023 and a low of 0.09 during Q4 2025
  • Over the past 5 years, Ocular Therapeutix's median Asset Utilization Ratio value was 0.16 (recorded in 2024), while the average stood at 0.21.
  • In the last 5 years, Ocular Therapeutix's Asset Utilization Ratio surged by 18687.13% in 2022 and then plummeted by 7338.98% in 2024.
  • Over the past 5 years, Ocular Therapeutix's Asset Utilization Ratio (Quarter) stood at 0.21 in 2021, then surged by 62.42% to 0.33 in 2022, then fell by 15.69% to 0.28 in 2023, then plummeted by 52.35% to 0.13 in 2024, then crashed by 36.57% to 0.09 in 2025.
  • Its last three reported values are 0.09 in Q4 2025, 0.13 for Q3 2025, and 0.13 during Q2 2025.